CJC-1295 (without DAC) and Hexarelin Interaction

Monitor

Researched 90% confidence

CJC-1295 (without DAC) and Hexarelin have an interaction requiring monitoring for interaction with 90% confidence. Can combine but watch for excessive GH elevation. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Half-life: 30 minutes - 2 hours Typical dose: 100-300mcg per injection growth hormone, weight loss

ghrh receptor carcinogenic riskestrogenicinsulin disruptingteratogenic

View full profile

Hexarelin

Examorelin | Synthetic Growth Hormone Secretagogue

Hexarelin binds to the growth hormone secretagogue receptor 1a (GHS-R1a) in the brain and pituitary gland. This binding initiates a signaling cascade that stimulates somatotroph cells in the anterior pituitary to produce and release growth hormone.

Half-life: 1-2 hours Typical dose: 100-200 mcg per injection growth hormone, weight loss

ghrelin receptorprolactin receptor carcinogenic riskinsulin disruptingprolactin elevatingteratogenic

View full profile

Combined Organ Load

GI Tract

low

Pituitary

low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (CJC-1295 (without DAC), Hexarelin). Monitor accordingly.

2x 2 compounds affect insulin sensitivity (CJC-1295 (without DAC), Hexarelin). Monitor fasting glucose and HbA1c.

2x 2 compounds share the teratogenic safety flag (CJC-1295 (without DAC), Hexarelin). Monitor accordingly.

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Hexarelin?

Yes, but with caution. Can combine but watch for excessive GH elevation. Regular monitoring is advised.

Is CJC-1295 (without DAC) and Hexarelin safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Hexarelin?

Can combine but watch for excessive GH elevation. This assessment has 90% confidence and is based on documented research data.

How should I time CJC-1295 (without DAC) and Hexarelin?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Hexarelin has a half-life of 1-2 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 (without DAC) vs Hexarelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.